Suguru Okami

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Chronic Kidney Disease

Glycemic Control

Transcatheter Aortic Valve Replacement

Top Venues

Diabetes, obesity & metabolism

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Atsuhisa Sato, Daloha Rodriguez-Molina, Kanae Yoshikawa-Ryan, Satoshi Yamashita, Suguru Okami, Fangfang Liu, Alfredo Farjat, Nikolaus G Oberprieler, Csaba Pal Kovesdy, Keizo Kanasaki, David Vizcaya
Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan-A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform. Journal of clinical medicine 13 (17) (2024)
Suguru Okami, Christoph Ohlmeier, Makiko Takeichi, Mireia Aguila, Katsiaryna Holl, Alexander Michel, Coralie Lecomte, Tomomi Ide
Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in Japan. Journal of clinical medicine 13 (11) (2024)
Suguru Okami, Christoph Ohlmeier, Makiko Takeichi, Mireia Aguila, Katsiaryna Holl, Alexander Michel, Coralie Lecomte, Tomomi Ide
Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in Japan. Journal of clinical medicine 13 (11) (2024)
Anna Norhammar, Johan Bodegard, Jan W Eriksson, Hermann Haller, Gerard C M Linssen, Amitava Banerjee, Avraham Karasik, Pavlos Mamouris, Navdeep Tangri, Tiago Taveira-Gomes, Aldo P Maggioni, Manuel Botana, Marcus Thuresson, Suguru Okami, Toshitaka Yajima, Takashi Kadowaki, Kåre Inge Birkeland, null null
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries. Diabetes, obesity & metabolism 24 (7) (2022)
Shun Kohsaka, Naru Morita, Suguru Okami, Yoko Kidani, Toshitaka Yajima
Current trends in diabetes mellitus database research in Japan. Diabetes, obesity & metabolism (2021)
Issei Komuro, Takashi Kadowaki, Johan Bodegard, Marcus Thuresson, Suguru Okami, Toshitaka Yajima
Lower heart failure and chronic kidney disease risks associated with sodium-glucose cotransporter-2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases. Diabetes, obesity & metabolism (2021)
Kåre Inge Birkeland, Johan Bodegard, Jan W Eriksson, Anna Norhammar, Hermann Haller, Gerard C M Linssen, Amitava Banerjee, Marcus Thuresson, Suguru Okami, Elena Garal-Pantaler, Jetty A Overbeek, Jil Billy Mamza, Ruiqi Zhang, Toshitaka Yajima, Issei Komuro, Takashi Kadowaki
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study. Diabetes, obesity & metabolism 22 (9) (2020)
Kåre Inge Birkeland, Johan Bodegard, Amitava Banerjee, Dae-Jung Kim, Anna Norhammar, Jan W Eriksson, Marcus Thuresson, Suguru Okami, Kyoung Hwa Ha, Nils Kossack, Jil Billy Mamza, Ruiqi Zhang, Toshitaka Yajima, Issei Komuro, Takashi Kadowaki
Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study. Diabetes, obesity & metabolism 23 (1) (2020)